You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Australia

Jul 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Australia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Australia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Australia for free:

The Consumer Health in Australia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Australia?
  • What are the major brands in Australia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

The future appears brighter for consumer health

After a period of recession, sales growth in 2010 suggests there is no more uncertainty due to the global financial crisis and that Australians have a positive outlook in terms of discretionary spending. Consumer health is expected to grow in the forecast period.

Preventive approach

2009 was a turbulent year in terms of public health fears. The outbreak of swine flu and H1N1 had a heavy influence on Australian consumers, persuading them to think more about preventive medicine and how this could be used to assure optimal health before an outbreak of flu, for example. 2010 therefore saw Australian consumers purchasing more vitamins and dietary supplements.

Sanofi-Aventis Healthcare retains its leadership in consumer health

Sanofi-Aventis Healthcare retained its leadership in overall consumer health sales in 2010. An expanded product portfolio from the acquisition of Symbion Health Ltd saw Sanofi-Aventis register strong growth in 2010. Sanofi-Aventis was followed by Blackmores Ltd. Growth was attributed to its product innovations, promotional campaigns and growth in core categories.

Supermarkets and the internet gain distribution share

The convenience presented by supermarkets and increasing hours spent on the internet resulted in increased distribution shares. Promotional discounts also helped supermarkets to gain share. Emergency contraceptive pills recorded the highest growth in sales via the internet.

Consumer health sales growth expected to remain steady over the forecast period

Sales growth in consumer health is expected to be steady over the forecast period, with strong performances expected in NRT smoking cessation aids, medicated skin care and weight management. Adult mouth care is also expected to record moderate growth, due to the poor state of oral health in Australia, the second worst amongst OECD (Organisation for Economic Co-operation and Development) countries. Consumer interest in natural products and preventive health are likely to drive interest in herbal/traditional products and vitamins and dietary supplements.

Table of Contents

Table of Contents

Consumer Health in Australia - Industry Overview

EXECUTIVE SUMMARY

The future appears brighter for consumer health

Preventive approach

Sanofi-Aventis Healthcare retains its leadership in consumer health

Supermarkets and the internet gain distribution share

Consumer health sales growth expected to remain steady over the forecast period

KEY TRENDS AND DEVELOPMENTS

Preventive approach to manage health

The state of Australia’s health in 2010

Regulation on medicine prices

Revised medicines and chemicals scheduling arrangements

Health-based content flourishes on the internet

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventive medicine

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Australia - Company Profiles

Blackmores Ltd in Consumer Health (Australia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 4 Blackmores Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 5 Blackmores Ltd: Competitive Position 2010

Ego Pharmaceuticals Pty Ltd in Consumer Health (Australia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Ego Pharmaceuticals Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 9 Ego Pharmaceuticals Ltd: Competitive Position 2010

Herron Pharmaceuticals Pty Ltd in Consumer Health (Australia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Herron Pharmaceuticals (Pty) Ltd: Competitive Position 2010

iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 14 iNova Pharmaceuticals (Australia) (Pty) Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 15 iNova Pharmaceuticals (Australia) (Pty) Ltd: Competitive Position 2010

Swisse Natural Health Products Pty Ltd in Consumer Health (Australia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 17 Swisse Natural Health Products Pty Ltd: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 18 Swisse Natural Health Products Pty Ltd: Competitive Position 2010

Adult Mouth Care in Australia - Category Analysis

HEADLINES

TRENDS

  • As per the National Advisory Committee on Oral Health, there were persistent high levels of oral disease among Australian adults in 2010. Poor oral health is most visible among people on low incomes, the rural and remote population and immigrant groups from non-English speaking countries.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Australia - Category Analysis

HEADLINES

TRENDS

  • In 2010, the growing trend of the sale and purchase of pharmaceutical products via the internet in Australia created an environment conducive to the unregulated supply of analgesics. E-pharmacies that conducted their business via the internet and community pharmacies that offered web portals alongside their main business contributed to the abuse of analgesics, particularly by younger consumers.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Australia Pty Ltd retained its leadership position in analgesics in 2010, with a value share of 26%. Sales growth for OTC analgesics was driven by strong sales of Panadol pain relief products.

PROSPECTS

  • With Australia witnessing an ageing demographic and increasingly busy lifestyles, analgesics is forecasted to grow by a 1% CAGR in value terms during the forecast period. Quick relief is one of the main priorities for Australians with a hectic lifestyle.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Australia - Category Analysis

HEADLINES

TRENDS

  • According to the research conducted in collaboration with the Sleep and Circadian Rhythm Group at the Woolcock Institute of Medical Research, sleep disorders including insomnia, sleep apnoea and restless legs syndrome, are a significant public health issue in Australia. The economic impact is A$10.3 billion annually.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Australia - Category Analysis

HEADLINES

TRENDS

  • After the swine flu pandemic, consumers had a less cautious approach and started using OTC medicine for colds and coughs instead of visiting the doctor to get prescriptions.

SWITCHES

COMPETITIVE LANDSCAPE

  • Schering-Plough emerged as the leader in cough, cold and allergy (hay fever) remedies in 2010 with an 18% value share. The company saw significant growth of its Demazin brand due to its cheaper price.

PROSPECTS

  • The growth in vaccinations and awareness about the side effects of cough, cold and allergy (hay fever) remedies during 2010 is likely to weaken over the forecast period. Consequently, growth is expected to remain below a 1% CAGR in constant value terms during the forecast period.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Australia - Category Analysis

HEADLINES

TRENDS

  • Growing awareness about digestive disorders led to a growth in sales of digestive remedies. It benefited from promotional and advertising activities by manufacturers and retailers in terms of both value and volume.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson continued to lead digestive remedies with a value share of 18% during 2010. The traditional hold of the company’s leading brand Mylanta in antacids and H2 Blockers, where is ranks in second place, continued to benefit sales in 2010. Mylanta had the highest brand share of 12% in 2010. Imodium is the company’s leading brand in diarrhoeal remedies and holds a 5% brand share.

PROSPECTS

  • Growth in digestive remedies is expected to continue to be driven by sociological factors such as rising obesity, growing ageing population and more hectic lifestyles in Australia. Digestive remedies is expected to post a CAGR of 1% in constant value terms during the forecast period.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Australia - Category Analysis

HEADLINES

TRENDS

  • Sales in ear care increased by 5% in current value terms in 2010 to reach A$12 million in Australia. There was no promotional or innovation activity.

SWITCHES

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Australia - Category Analysis

TRENDS

  • In 2010, emergency contraception grew by 8% in current value terms to reach A$1 million.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Australia - Category Analysis

HEADLINES

TRENDS

  • Eye care grew by 4% in current value in 2010 to reach A$120 million. Standard eye care had 78% of market share in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Allergan Australia Pty Ltd maintained its leading position in eye care sales in 2010 with a 33% value share, gaining from increases in brand shares of Refresh and Cellufresh in standard eye care. Alcon Laboratories (Aust) Pty Ltd remained at number two with 28% value share. With 15% value share, Refresh from Allergan Australia remained the leading brand in eye care.

PROSPECTS

  • Eye care is predicted to grow by a 1% CAGR in constant value terms during the forecast period. Sales in eye care will be driven by the growing awareness of dry eye, which is increasing in an ageing population, as well as the growing interest by consumers in treating and preventing allergy conjunctivitis with eye care products.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Australia - Category Analysis

HEADLINES

TRENDS

  • In 2009, herbal/traditional products was subjected to greater scrutiny by regulatory bodies over its efficacy and safety. The TGA released proposed guidelines on herbal products targeted for weight loss that would require testing on humans rather than on animals or in test tubes, should the proposal be approved. For such a product to be considered as effective in facilitating weight loss, the herbal product would have to result in at least a 5% reduction in body weight as well as at least 3% higher weight loss as compared to a placebo pill.

COMPETITIVE LANDSCAPE

  • Medicated confectionery products dominated herbal/traditional products in 2010, with the top three leading brands. Nestlé Australia Ltd Allen’s brand maintained its lead with a 32% in 2010.

PROSPECTS

  • Although the negative publicity surrounding herbal/traditional products did not result in value loss for the category during 2010, the issues raised about product efficacy and more importantly, safety, could depress sales over the forecast period if manufacturers and regulatory bodies are not seen to be addressing them. Continuous criticism of such products could lead to decreased confidence amongst consumers who perceive herbal alternatives as better for their overall health and have acceptable levels of efficacy.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Australia - Category Analysis

HEADLINES

TRENDS

  • In 2010, post the swine flu period, consumers had a more normal approach towards skin care leading to lower growth in medicated skin care compared to 2009.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated skin care continued to be led by Johnson & Johnson with a 21% value share in 2010. Established and wide ranging brands across medicated skin care include Clean & Clear in acne treatments, Hemocane and Rectinol in haemorrhoid treatments and Daktarin in topical antifungals. Johnson & Johnson also carries an established brand equity associated with being safe and effective with Australian consumers.

PROSPECTS

  • Medicated skin care is expected to record a 1% constant value CAGR over the forecast period. The steadiness in value sales of medicated skin care can be attributed to the environmental conditions that contribute to topical allergic reactions, persistently dry skin leading to eczema and fungal infections from the humidity experienced during the warmer seasons of the year.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Australia - Category Analysis

HEADLINES

TRENDS

  • Australians’ interest in sports and personal fitness partly benefited from the economic downturn, which resulted in job losses and financial uncertainty for some. Many lost control over their personal employment or in ensuring a steady income, which in turn led them to focus on what they could personally control and influence, which included their personal fitness.

COMPETITIVE LANDSCAPE

  • Sports nutrition continued to be led by Musashi Pty Ltd, which held a 36% value share in 2010. The company’s strong performance is attributed to the wide range of products, particularly in the increasingly popular ready to drink format.

PROSPECTS

  • Sports nutrition is expected to post improved growth of 4% CAGR in constant value terms during the forecast period, sustained by consumer interest in supplementing their training regimes to reach better personal fitness. Attaining strong muscular physiques is highly sought after by Australian males, particularly young adults, as such a physique is associated with social and personal success.

CATEGORY DATA

  • Table 81 Sales of Sports Nutrition: Value 2005-2010
  • Table 82 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 83 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 84 Sports Nutrition Company Shares 2006-2010
  • Table 85 Sports Nutrition Brand Shares 2007-2010
  • Table 86 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 87 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Australia - Category Analysis

HEADLINES

TRENDS

  • With the first case of swine flu discovered at the start of the winter season in 2009, it quickly developed to record over a thousand sufferers in Australia within a month. Since aspects of the disease were not known, such as the associated morbidity, the Australian public as well as health agencies took several precautionary measures to restrict the rapid onset of the influenza.

Vitamins

Dietary Supplements

COMPETITIVE LANDSCAPE

  • Through the acquisition of Symbion Health Ltd in 2009, Sanofi-Aventis Healthcare Pty Ltd gained the lead in vitamins and dietary supplements with a value share of 26% during 2010 The company holds a portfolio of brands which include Nature’s Own, Cenovis, Bio-Organics and Golden Glow, which are present in every segment in vitamins and dietary supplements.

PROSPECTS

  • The Australian is receptive to consuming vitamins and dietary supplements as part of a daily routine to boost overall health and well-being as well as to address specific conditions related to lifestyle or ageing. Vitamins and dietary supplements is also supported by research studies and efficacy trials showing the benefits of certain products. Sales in vitamins and dietary supplements are expected to grow by a 3% CAGR in constant value terms during the forecast period.

CATEGORY DATA

  • Table 88 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 90 Dietary Supplements by Positioning 2005-2010
  • Table 91 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 92 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 93 Vitamins Brand Shares by Value 2007-2010
  • Table 94 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Wound Care in Australia - Category Analysis

HEADLINES

TRENDS

  • Wound care is a low priority health issue in Australia which negatively impacted sales in 2010.

CATEGORY DATA

  • Table 97 Sales of Wound Care by Category: Value 2005-2010
  • Table 98 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 99 Wound Care Company Shares by Value 2006-2010
  • Table 100 Wound Care Brand Shares by Value 2007-2010
  • Table 101 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 102 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Isoflavones
            • Milk Thistle
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Child-Specific Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Child-Specific Consumer Health
        • Child-Specific Analgesics
          • Child-Specific Acetaminophen
          • Child-Specific Aspirin
          • Child-Specific Combination Products - Analgesics
          • Child-Specific Diclofenac
          • Child-Specific Dipyrone
          • Child-Specific Ibuprofen
          • Child-Specific Ketoprofen
          • Child-Specific Naproxen
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Child-Specific Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Child-Specific Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by format
    • Analysis by positioning
    • Analysis by type
    • Herbal/traditional vs standard
    • Pricing
    • Smoking population - number of adult smokers
    • Smoking prevalence - % of adult population

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices % growth
    • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices % growth
    • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices % growth
    • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices % growth
    • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    RELATED

    Future Demographic

    Country Report

    Consumer Lifestyle

    Country Report